Largest companies by market cap
market cap
| Company | Market cap | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 201 | $2.33B | Healthcare | Medical Devices | United States | Nasdaq |
| 202 | $2.33B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 203 | $2.33B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 204 | $2.32B | Healthcare | Medical Devices | United States | Nasdaq |
| 205 | $2.27B | Healthcare | Biotechnology | United States | Nasdaq |
| 206 | $2.27B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 207 | $2.26B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 208 | $2.22B | Healthcare | Pharmaceuticals | United States | NYSE |
| 209 | $2.20B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 210 | $2.16B | Healthcare | Biotechnology | United States | Nasdaq |
| 211 | $2.16B | Healthcare | Pharmaceuticals | United States | NYSE |
| 212 | $2.13B | Healthcare | Healthcare Providers | United States | NYSE |
| 213 | $2.10B | Healthcare | Pharmaceuticals | United States | NYSE |
| 214 | $2.09B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 215 | $2.06B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 216 | $2.06B | Healthcare | Biotechnology | United States | Nasdaq |
| 217 | $2.05B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 218 | $2.02B | Healthcare | Medical Devices | United States | NYSE |
| 219 | $2.02B | Healthcare | Pharmaceuticals | United States | NYSE |
| 220 | $2.01B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 221 | $2.00B | Healthcare | Pharmaceuticals | United States | NYSE |
| 222 | $2.00B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 223 | $2.00B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 224 | $1.99B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 225 | $1.98B | Healthcare | Biotechnology | United States | Nasdaq |
| 226 | $1.96B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 227 | $1.95B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 228 | $1.95B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 229 | $1.92B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 230 | $1.92B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 231 | $1.91B | Healthcare | Medical Devices | United States | Nasdaq |
| 232 | $1.91B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 233 | $1.91B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 234 | $1.90B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 235 | $1.90B | Healthcare | Pharmaceuticals | — | Nasdaq |
| 236 | $1.88B | Healthcare | Medical Devices | United States | Nasdaq |
| 237 | $1.88B | Healthcare | Biotechnology | United States | Nasdaq |
| 238 | $1.85B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 239 | $1.85B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 240 | $1.84B | Healthcare | Medical Devices | United States | Nasdaq |
| 241 | $1.81B | Healthcare | Healthcare Providers | United States | NYSE |
| 242 | $1.80B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 243 | $1.79B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 244 | $1.78B | Healthcare | Biotechnology | United States | Nasdaq |
| 245 | $1.78B | Healthcare | Biotechnology | United States | Nasdaq |
| 246 | $1.74B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 247 | $1.69B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 248 | $1.68B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 249 | $1.68B | Healthcare | Medical Devices | United States | Nasdaq |
| 250 | $1.65B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 251 | $1.63B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 252 | $1.63B | Healthcare | Biotechnology | United States | Nasdaq |
| 253 | $1.60B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 254 | $1.60B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 255 | $1.59B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 256 | $1.55B | Healthcare | Medical Devices | United States | Nasdaq |
| 257 | $1.55B | Healthcare | Biotechnology | United States | Nasdaq |
| 258 | $1.53B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 259 | $1.50B | Healthcare | Biotechnology | United States | Nasdaq |
| 260 | $1.49B | Healthcare | Biotechnology | United States | Nasdaq |
| 261 | $1.48B | Healthcare | Healthcare Providers | United States | NYSE |
| 262 | $1.44B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 263 | $1.44B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 264 | $1.43B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 265 | $1.43B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 266 | $1.42B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 267 | $1.41B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 268 | $1.39B | Healthcare | Medical Devices | United States | NYSE |
| 269 | $1.38B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 270 | $1.38B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 271 | $1.34B | Healthcare | Healthcare Providers | United States | NYSE |
| 272 | $1.28B | Healthcare | Healthcare Providers | United States | NYSE |
| 273 | $1.28B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 274 | $1.28B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 275 | $1.27B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 276 | $1.27B | Healthcare | Medical Devices | United States | Nasdaq |
| 277 | $1.26B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 278 | $1.24B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 279 | $1.23B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 280 | $1.23B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 281 | $1.22B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 282 | $1.22B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 283 | $1.19B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 284 | $1.18B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 285 | $1.18B | Healthcare | Biotechnology | United States | Nasdaq |
| 286 | $1.17B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 287 | $1.16B | Healthcare | Pharmaceuticals | — | Nasdaq |
| 288 | $1.15B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 289 | $1.14B | Healthcare | Medical Devices | United States | Nasdaq |
| 290 | $1.12B | Healthcare | Medical Devices | United States | NYSE |
| 291 | $1.12B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 292 | $1.11B | Healthcare | Medical Devices | United States | Nasdaq |
| 293 | $1.10B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 294 | $1.08B | Healthcare | Biotechnology | United States | Nasdaq |
| 295 | $1.08B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 296 | $1.07B | Healthcare | Healthcare Providers | United States | NYSE |
| 297 | $1.07B | Healthcare | Biotechnology | United States | Nasdaq |
| 298 | $1.05B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 299 | $1.05B | Healthcare | Pharmaceuticals | United States | NYSE |
| 300 | $1.05B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
U.S.-exchange common stocks; ADRs and funds excluded. 890 companies. Market capitalization in USD.